7 mayo 2015
Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn’t take statins, a clinical trial shows.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/1kQZSFgxWfo/150507114004.htm
